版本:
中国

BRIEF-Allergan receives FDA clearance for a new surgical treatment for refractory glaucoma

Nov 22 Allergan Plc :

* Allergan receives FDA clearance for the xen gel stent, a new surgical treatment for refractory glaucoma

* Allergan Plc - Allergan plans to launch xen in U.S. In early 2017

* Allergan Plc - Allergan plans to launch xen glaucoma treatment system in U.S. in early 2017 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐